BDBM735216 1-(4-(8-((4-(imidazo[1,2-b]pyridazin-7-yloxy)-3-methylphenyl)amino)pyrimido[5,4-d]pyrimidin-2-yl)piperazin-1-yl)prop-2-en-1-one ::US20250129078, Compound 234

SMILES C=CC(=O)N1CCN(c2ncc3ncnc(Nc4ccc(Oc5cnn6ccnc6c5)c(C)c4)c3n2)CC1

InChI Key

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 735216   

TargetReceptor tyrosine-protein kinase erbB-2 [V777L](Homo sapiens (Human))
Cogent Biosciences

US Patent
LigandPNGBDBM735216(1-(4-(8-((4-(imidazo[1,2-b]pyridazin-7-yloxy)-3-me...)
Affinity DataIC50: 50nMAssay Description:In vitro enzyme assays based on CisBio HTRF-KinEASE-TK technology were used to determine compound potencies. EGFR WT (Invitrogen, cat #PR7295B) at 0....More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
US Patent